Glasgow, United Kingdom
Nebu~Flow is a United Kingdom-based startup founded in 2019, with the mission of transforming respiratory drug delivery. The company is focused on developing the next generation of nebulisers to facilitate the delivery of the next generation of inhaled drugs. Recently, Nebu~Flow received a significant financial boost through a Venture Round investment on 29th April 2024.
This investment round saw participation from a range of notable investors, including Ascension Ventures (UK), Foresight Group, SIS Ventures, Scottish Enterprise, Foresight WAE Technology, SCVC, and The Conduit Connect. The diverse group of investors reflects the widespread interest and support for Nebu~Flow's innovative approach to respiratory drug delivery.
Nebu~Flow's emphasis on unlocking the potential of inhaled drugs aligns with the growing trend of advancements in healthcare technologies. With the ongoing development of its nebuliser technology, the company is well-positioned to meet the increasing demand for more effective and targeted respiratory drug delivery methods.
Overall, Nebu~Flow's ability to attract a significant Venture Round investment and garner support from a range of reputable investors underscores the potential and promise of its approach to transforming respiratory drug delivery. The company's progress and partnerships make it one to watch in the evolving landscape of healthcare startups.
